BioDlink International Company Limited (1875.HK) HKSE

1.71

-0.01(-0.58%)

Updated at December 05 01:13PM

Currency In HKD

Valuation

Market Cap1.22B
Enterprise Value1.23B
P/E Ratio155.05
PEG Ratio-1.96
Price/Sales Ratio1.12
Price/Book Ratio1.54
Enterprise/Revenue1.14
Enterprise/EBITDA27.66

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.02

Management Effectiveness

Return On Assets0
Return On Equity0.01

Income Statement

Revenue1.1B
Revenue/Share1.47
Gross Profit782.43M
EBITDA84.96M
Net Income34.76M
Diluted EPS0.05

Balance Sheet

Total Cash383.98M
Total Cash/Share0.53
Total Debt397.2M
Total Debt/Equity0.54
Current Ratio2.09
Book Value Per Share1.01

Price History

52-Week Change-5
52-Week High2.94
52-Week Low1.48
Moving Average 50 Days2.01
Moving Average 200 Days2.03

Statistics

Average Volume182,040
Shares Outstanding772.6M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A